C hronic thromboembolic pulmonary hypertension (CTEPH) is classified into group 4 as a cause of pulmonary hypertension according to the latest guideline for pulmonary hypertension.1 It results from organized thrombi causing pulmonary artery stenosis/occlusion and leads to abnormal pulmonary blood flow distribution in lung perfusion scanning. Furthermore, it results in pulmonary hypertension, hypoxia, and right ventricular failure.2 If left untreated, the 3-year survival rate for patients with a mean pulmonary arterial pressure of ≥30 mm Hg at the time of definitive diagnosis is poor. 3,4 Pulmonary endarterectomy (PEA) is the only curative treatment for selected CTEPH patients.2 Although the mortality rate among the most experienced institutes is as low as 2.2%, 5 these excellent outcomes are not applicable worldwide, where it can be as high as 14.3%. [6][7][8][9] Moreover, the rate of inoperable CTEPH varies from 12.0% to 60.9%. Balloon pulmonary angioplasty (BPA) is an alternative therapy for CTEPH patients who are ineligible for PEA. 10,11 Recently, the efficacy of BPA in improving hemodynamics and exercise capacity has been established by case series reported by several groups, including our group. 12,13 There is a learning curve to safely and successfully perform BPA, as previously mentioned.12 As our group has accumulated experience with BPA, we noted that some types of lesions were associated with better BPA success and a lower rate of complications when compared with other types of lesions. This is similar to the variance in outcomes and complications associated with specific types of lesions when performing percutaneous coronary intervention (PCI) for patients with coronary artery diseases. PCI is performed based on a classification of coronary angiogram. In PCI, a classification of lesion type based on the success rate of the procedure is widely used.14 There are several classifications Background-Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for standard therapy, pulmonary endarterectomy. Although there are several classifications of vascular lesions, these classifications are based on the features of the specimen removed during pulmonary endarterectomy. Because organized thrombi are not removed during balloon pulmonary angioplasty, we attempted to establish a new classification of vascular lesions based on pulmonary angiographic images. We evaluated the success and complication rate of BPA in accordance with the location and morphology of thromboembolic lesions. Methods and Results-We reviewed 500 consecutive procedures (1936 lesions) of BPA in 97 patients with chronic thromboembolic pulmonary hypertension and investigated the outcomes of BPA based on the lesion distribution and the angiographic characteristics of the thromboembolic lesions, as follows: type A, ring-like stenosis lesion; type B, web lesion; type C, subtotal lesion; type D, total occlusion lesion, and type E, tortuous lesion. The success ...